God Gift Laboratory Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 2.00 Cr
as on 24-10-2024
- Company Age 32 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.30 Cr
as on 24-10-2024
- Satisfied Charges ₹ 2.08 Cr
as on 24-10-2024
- Revenue 20.38%
(FY 2023)
- Profit 0.16%
(FY 2023)
- Ebitda -60.09%
(FY 2023)
- Net Worth 10.74%
(FY 2023)
- Total Assets 61.90%
(FY 2023)
About God Gift Laboratory
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹11.30 Cr. The company has closed loans amounting to ₹2.08 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pramod Sethi and Manish Kumar serve as directors at the Company.
- CIN/LLPIN
U74899DL1992PTC051019
- Company No.
051019
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Nov 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at God Gift Laboratory?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramod Sethi  | Director | 10-Feb-2003 | Current |
Manish Kumar  | Director | 09-Mar-2007 | Current |
Financial Performance of God Gift Laboratory.
God Gift Laboratory Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.38% increase. The company also saw a slight improvement in profitability, with a 0.16% increase in profit. The company's net worth Soared by an impressive increase of 10.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of God Gift Laboratory?
In 2022, God Gift Laboratory had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Manpra Pharm Private LimitedActive 19 years 4 months
Pramod Sethi and Manish Kumar are mutual person
- Save Earth Labs Private LimitedActive 3 years 6 months
Pramod Sethi and Manish Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Jul 2023 | ₹3.80 Cr | Open |
Axis Bank Limited Creation Date: 29 Dec 2022 | ₹5.00 M | Open |
Others Creation Date: 29 Jun 2022 | ₹2.70 Cr | Open |
How Many Employees Work at God Gift Laboratory?
Unlock and access historical data on people associated with God Gift Laboratory, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of God Gift Laboratory, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped God Gift Laboratory's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
